Document O1Br6q3M4akDrY9yvm3MbB2Y1

FILE NAME: DuPont (DUP) DATE: 1966 Nov 8 DOC#: DUP049 DOCUMENT DESCRIPTION: Memo to All Plant Physicians from C.A. D'Alonzo, M.D. RE Asbestos EMPLOYEE RELATIONS DEPARTMENT MEDICAL DIVISION/' ,,u..ro .f.. WILMINGTON, DELAWARE Exr""" ' ,,.c. // c... T ^-5 TO: ALL PLANT PHYSICIANS FROM: C. A. D'ALONZO,VM . D . '` .- .--OZZ7 'November 8, 1966 / ,,.L \ /> Dr. Zahn and I believe that the following nay be of interest to you: . 1. ASEESTOS - During the past year, a report was sent to you outlining the alleged increasing incidence and concern over asbestosis, mesothelioma, and other related carcinomas in people with relatively minor exposure to asbestos. We are enclosing two more obviously controversial articles on this subject, presenting both sides of the question, for your consideration. In an effort to define our problem in this area and to develop the necessary preventive measures, where indicated, we are asking you to provide us with the following information and to return it to us as soon as possible. A. How many full-time insulators do you have on your plant? S. How many employees do part-time insulating? (a) What proportion of the time? C. List the (three) most prevalent type of insulating material used. D. Are they doing any spraying of insulating materials at your location? a - 2- Give the number of each of the following has experienced, if any: (a) Asbestosis (b) Mesothelioma (c) Carcinomas smong insulators your plant F. List briefly any preventive measures or safety equipment required in your location when: (a) saving insulating materials (b) removing obsolete insulation (c) spraying insulating materials 2 FUNCTION TEST - With the increasing incidence of chronic bronchitis, emphysema, lung cancer, etc., it is imperative that we obtain as much information as possible on our employees pulmonary status to: A. guide us in providing the necessary preventive measures. - E. accumulate data for possible legal action in the future. In connection with this point, a pilot study is underway at Chambers Work, using equipment end tests recommended by Dr. Tcmashefski, a specialist in pulmonary function.screening tests at the Ohio State University Medical Center, to determine our best plan of action. In the future, definite recommendations will be forthcoming concerning equipment, tests, and programs. It is suggested that you refrain from purchasing any ex pensive equipment or initiating any definitive program until such recommendations are received, so to insure a uniform company-wide policy. t> 330 3. "SHXETiL" - By now, I am hopeful that the Pharmaceutical Division of our 1. & B. Department, hes sent each of you a packet of information regarding "Sy^etrel". Du Font's new anti-influenra drug. I Wish to stress to each of you that this drug is for the prevention of influenza, and not a cure. It appears to be effective primarily against the A 2 strain. We had a meeting today with their Marketing Division. ou will each shortly receive a c o t a t i o n from Mr. Harry B. Boos, dealing with the central purchasing of this drug, and which ill. give your plant the wholesale rate. 1 am sure that the communication, , a y r Roos vill be self-explanatory and will which you vill receive from Kr. Roos, wiii. arrive shortly. 4. BOARD OF ^r.-.a-nnKAL MEPICHS - thoS` f you who may be preparing for the American Board of Occupational Medicine, we wish to call your attention to the "First Western Insti tute on Occupational Medicine," from March 20-25,1967, at the Uni versity of California, Berkeley, California. Dr. Tabershaw has discussed this course witn us and it is uade as practical and complete as possible with the view of preparing one for the Board Examinations. C A D 'A/ag Enc.-2